Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × durvalumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 17 Small Cell Lung Carcinoma 9 Urinary Bladder Neoplasms 7 Carcinoma, Hepatocellular 7 Neoplasms 6 Liver Neoplasms 5 Cholangiocarcinoma 5 Biliary Tract Neoplasms 5 Neoplasms by Site 3 Triple Negative Breast Neoplasms 2 Thoracic Neoplasms 2 Stomach Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lung Diseases 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Bronchogenic 2 Carcinoma 2 Bronchial Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1

Interventions

Cyclophosphamide 19 fludarabine 14 fludarabine phosphate 10 Vincristine 10 Methotrexate 9 venetoclax 8 Melphalan 8 Granulocyte Colony-Stimulating Factor 8 Filgrastim 8 blinatumomab 7 Whole-Body Irradiation 7 Dexamethasone 7 Cytarabine 7 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Mycophenolic Acid 5 Mesna 5 Doxorubicin 5 Calcium Dobesilate 5 ponatinib 4 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 calaspargase pegol 4 Thiotepa 4 Tacrolimus 4 Specimen Handling 4 Rituximab 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡